Venous Thrombosis or Pulmonary Embolism
Conditions
Keywords
Deep Vein Thrombosis, Superficial Vein Thrombosis, Anticoagulant, Patient Compliance, Preference, Venous Thrombosis, pulmonary embolism
Brief summary
The objective of the anticoagchoice study is to analyze the preferences of people suffering from phlebitis, in terms of anticoagulant, to improve adherence to these treatments, to adapt the medical prescriptions.
Detailed description
Venous thromboembolism (VTE) is the third leading cause of cardiovascular death, with an increase in annual incidence with age. With the advent of direct oral anticoagulants, the management of deep vein thrombosis and pulmonary embolism has evolved in recent years and these treatments are widely prescribed. There are studies comparing the different anticoagulant treatments used in venous thrombosis, which show no inferiority of treatment (injectable or oral) compared to others. Drug delivery modalities have been shown to affect adherence, and thus treatment efficacy. It seems fundamental to focus on patients' drug preferences in VTE to ensure the best possible compliance. These preferences seem to depend on the personal history of each patient. In addition, no studies have been conducted on patient preferences for anticoagulant therapy for VTE: this is the goal of the anticoagchoice study.
Interventions
OTHERanticoagulation choice
Type of anticoagulant chosen by the patient (oral or injectable).
Sponsors
SFMV (French Society of Vascular Medicine)
Rennes University Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients with deep vein thrombosis, superficial vein thrombosis, muscle vein thrombosis or pulmonary embolism, over 18 years of age. No
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The primary objective of this study is to analyze patient treatment preferences in venous thromboembolic disease. | the time required for a consultation: 30 minutes | The primary outcome: To compare the proportion of patients choosing oral anticoagulation vs patients choosing injectable route. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| compare patients choosing oral anticoagulation vs patients choosing an injectable route | the time required for a consultation: 30 minutes | proportions of patients choosing an oral anticoagulation vs. patients choosing an injectable pathway depending on the duration of treatment (3 months, 6 months or more), |
Countries
France
Contacts
Primary ContactCecile Ferragu
Backup Contactdirection de la recherche clinique
Outcome results
None listed